Enhanced Drug Delivery via Localization-Enabled Relaying in Molecular Communication Nanonetworks

Ethungshan Shitiri, Akarsh Yadav, Sergi Abadal, Eduard Alarcón, Ho-Shin Cho

Abstract

Intra-body nanonetworks hold promise for advancing targeted drug delivery (TDD) systems through molecular communications (MC). In the baseline MC-TDD system, drug-loaded nanomachines (DgNs) are positioned near the infected tissues to deliver drug molecules directly. To mitigate the decline in drug delivery efficiency caused by diffusion, we propose an enhanced MC-TDD system with a relay network. This network employs a novel localization-enabled relaying mechanism, where a nano-controller broadcasts a localization signal. DgNs then measure the received signal strength against thresholds to determine their clusters relative to the infected tissue. Additionally, our study considers the effect of multiple absorbing DgNs on the channel impulse response (CIR), a factor overlooked in previous works. Our approach improves drug delivery efficiency by $17\%$ compared to the baseline system. Importantly, we find that optimizing CIR is crucial for enhancing drug delivery efficiency. These findings pave the way for further research into optimizing CIR-based relay selection, as well as investigating the impact of factors such as drug molecule lifespan, obstruction probabilities, and flow dynamics.

Introduction

Targeted Drug Delivery (TDD) aims to release medication precisely at the site of infection or tumor, thereby minimizing systemic side effects in healthy tissue. In the context of nanotechnology, this is achieved using Drug-loaded Nanomachines (DgNs). However, these machines rely on Molecular Communication (MC), where molecules propagate via random diffusion. This stochastic nature often leads to many drug molecules drifting away before they can reach the intended target.

While relaying mechanisms can theoretically improve delivery by passing molecules along, they introduce the significant challenge of localization. Conventional positioning systems like GPS are non-functional within the human body, and complex algorithms are often too energy-intensive for simple nanomachines. Furthermore, existing models frequently ignore the physical reality of "competitive absorption," where multiple nanomachines in a medium alter the communication channel by absorbing molecules intended for others.

System Architecture and Methodology

The proposed system consists of a nano-controller, multiple DgNs, and a target area comprising both infected and healthy tissue. To evaluate this architecture, the researchers employed Monte Carlo simulations (4,000 repetitions per data point) using parameters derived from biological literature, such as realistic diffusion coefficients and nanomachine radii.

Overview of the MC-TDD system architecture involving a nano-controller, drug-loaded nanomachines (DgNs), and target tissue.

A core technical contribution is the implementation of the Multiple-receiver (MX) Channel model. Unlike simpler models, the MX model accounts for how multiple absorbing bodies (the DgNs) affect the Channel Impulse Response (CIR). This captures the "shadowing" effect where upstream nanomachines may deplete the concentration of molecules available to downstream receivers.

Localization-Enabled Relaying Mechanism

The enhanced MC-TDD system operates in two distinct phases:

  1. Localization Phase: A central nano-controller broadcasts a burst of localization molecules. Each DgN measures the local concentration. Based on pre-defined thresholds, DgNs self-classify into clusters (e.g., Cluster 0 is far from the target, while Cluster $N$ is closest). This low-complexity approach allows for relative positioning without requiring absolute coordinates.
  2. Drug Delivery Phase: DgNs release their payload. Molecules reach the infected tissue either through a direct link or a relay link, where they are captured and re-released by a downstream cluster.
Illustration of the communication channels: (a) localization broadcast from the nano-controller and (b) drug delivery via direct and relay links between clusters.

Key Results and Insights

  • Efficiency Gains: The relaying system achieved a 17% increase in drug delivery efficiency compared to baseline non-relay systems.
  • The "Crowding" Trade-off: While more relays provide more paths for drug molecules, they also increase the number of absorbers in the medium, which can degrade the CIR for direct links. The study identified a "sweet spot" where relaying benefits outweigh these absorption losses.
  • CIR Optimization: Peak efficiency was not necessarily tied to the highest number of relay links, but rather to the optimal tuning of localization thresholds (found to be approximately 30 molecules). This suggests that the spatial distribution of relays is more critical than their sheer quantity.
  • Robustness: By using clusters rather than point-to-point links, the system achieves built-in diversity. Any nanomachine in a downstream cluster can relay for any machine in an upstream cluster, making the network resilient to individual node failures.

Conclusion

This research demonstrates that even simple, "low-intelligence" nanomachines can perform complex coordinated tasks like self-organization into relay networks. Future work will focus on incorporating fluid dynamics (blood flow), the presence of physical obstructions like cells, and the finite lifespan of drug molecules in biological environments.

Summary updated

Abstract

Intra-body nanonetworks hold promise for advancing targeted drug delivery (TDD) systems through molecular communications (MC). In the baseline MC-TDD system, drug-loaded nanomachines (DgNs) are positioned near the infected tissues to deliver drug molecules directly. To mitigate the decline in drug delivery efficiency caused by diffusion, we propose an enhanced MC-TDD system with a relay network. This network employs a novel localization-enabled relaying mechanism, where a nano-controller broadcasts a localization signal. DgNs then measure the received signal strength against thresholds to determine their clusters relative to the infected tissue. Additionally, our study considers the effect of multiple absorbing DgNs on the channel impulse response (CIR), a factor overlooked in previous works. Our approach improves drug delivery efficiency by $17\%$ compared to the baseline system. Importantly, we find that optimizing CIR is crucial for enhancing drug delivery efficiency. These findings pave the way for further research into optimizing CIR-based relay selection, as well as investigating the impact of factors such as drug molecule lifespan, obstruction probabilities, and flow dynamics.
BibTeX
@inproceedings{shitiri2024enhanced,
  author = {Ethungshan Shitiri and Akarsh Yadav and Sergi Abadal and Eduard Alarcón and Ho-Shin Cho},
  title = {{Enhanced Drug Delivery via Localization-Enabled Relaying in Molecular Communication Nanonetworks}},
  booktitle = {NANOCOM},
  year = {2024},
  url = {https://openreview.net/forum?id=95lg1DPt5Q},
}
Figure